Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells

Journal of Biochemical and Biophysical Methods

Volumn 37, Issue 3, 1998, Pages 105-116

  Sinha, Pranav ^a   Hütter, Gero ^a   Köttgen, Eckart ^a   Dietel, Manfred ^a   Schadendorf, Dirk ^b   Lage, Hermann ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Klin Kooperationseinheit D   (Germany)

Author keywords

Chemoresistance; Daunorubicin; Microsequencing; Mitoxantrone; Stomach cancer

Indexed keywords

ANAZOLENE SODIUM; DAUNORUBICIN; LIPOCORTIN 1; MITOXANTRONE; THIOREDOXIN;

ARTICLE; CANCER CELL CULTURE; DRUG RESISTANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANNEXIN A1; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MITOXANTRONE; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; THIOREDOXIN; TUMOR CELLS, CULTURED;

EID: 0345516042     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(98)00020-7     Document Type: Article

References (43)

1. Dietel M. What's new in cytostatic drug resistance and pathology? Path Res Pract. 187:1991;892-905.
2. Schadendorf D., Czarnetzki B.M. [Drug resistance of malignant melanoma. Mechanisms and possible modulation]. Hautarzt. 45:1994;678-684.
3. Wang Y.Y., Teicher B.A., Shea T.C., Holden S.A., Rosbe K.W., al Achi A., Henner W.D. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res. 49:1989;6185-6192.
4. Zhang K., Mack P., Wong K.P. Glutathione-related mechanisms in cellular resistance to anticancer drugs. Int J Oncol. 12:1998;871-882.
5. Mirski S.E., Evans C.D., Almquist K.C., Slovak M.L., Cole S.P. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16. Cancer Res. 53:1993;4866-4873.
6. Evans C.D., Mirski S.E., Danks M.K., Cole S.P. Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell line. Cancer Chemother Pharmacol. 34:1994;242-248.
7. Preuss I., Thust R., Kaina B. Protective effect of O6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int J Cancer. 65:1996;506-512.
8. Yokomizo A., Ono M., Nanri H., Makino Y., Ohga T., Wada M., Okamoto T., Yodoi J., Kuwano M., Kohno K. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res. 55:1995;4293-4296.
9. Dietel M., Arps H., Lage H., Niendorf A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res. 50:1990;6100-6106.
10. Seidel A., Hasmann M., Loser R., Bunge A., Schaefer B., Herzig I., Steidtmann K., Dietel M. Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells. Virchows Arch. 426:1995;249-256.
11. Lage H, Jordan A, Scholz R, Dietel M. Thermosensitivity of multidrug-resistant gastric and pancreatic carcinoma cells. Int J Hyperthermia, submitted, 1998.
12. Rabilloud T., Valette C., Lawrence J.J. Sample application by in-gel rehydration improves the resolution of two-dimensional electrophoresis with immobilized pH gradients in the first dimension. Electrophoresis. 15:1994;1552-1558.
13. Cheung C.K., Mak Y.T., Swaminathan R. Automated trichloroacetic acid precipitation method for urine total protein. Ann Clin Biochem. 24:1987;140-144.
14. Dossi G., Celentano F., Gianazza E., Righetti P.G. Isoelectric focusing in immobilized pH gradients: generation of extended pH intervals. J Biochem Biophys Methods. 7:1983;123-142.
15. Gianazza E., Dossi G., Celentano F., Righetti P.G. Isoelectric focusing in immobilized pH gradients: generation and optimization of wide pH intervals with two-chamber mixers. J Biochem Biophys Methods. 8:1983;109-133.
16. Righetti P.G., Gianazza E., Bjellqvist B. Modern aspects of isoelectric focusing: two-dimensional maps and immobilized pH gradients. J Biochem Biophys Methods. 8:1983;89-108.
17. Righetti PG. Immobilized pH Gradients: Theory and Methodology, Elsevier, Amsterdam, New York, Oxford, 1990, pp. 53-116.
18. Neuhoff V., Arnold N., Taube D., Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R250. Electrophoresis. 9:1988;255-262.
19. Neuhoff V., Stamm R., Pardowitz I., Arnold N., Ehrhardt W., Taube D. Essential problems in quantification of proteins following colloidal staining with coomassie brilliant blue dyes in polyacrylamide gels, and their solution. Electrophoresis. 11:1990;101-117.
20. Aguilar F., Brunner B., Gardet Salvi L., Stutz E., Schurmann P. Biosynthesis of active spinach-chloroplast thioredoxin f in transformed E. coli. Plant Mol Biol. 20:1992;301-306.
21. Agostino A., Hatch M.D. A procedure for the purification of thioredoxin-m from leaves of the C4 plant Zea mays. Protein Expr Purif. 4:1993;434-437.
22. Barenboim M.G., Shingarova L.N., Korobko V.G. [Cloning and expression of the Escherichia coli thioredoxin gene]. Bioorg Khim. 21:1995;524-527.
23. Ben Menachem G., Himmelreich R., Herrmann R., Aharonowitz Y., Rottem S. The thioredoxin reductase system of mycoplasmas. Microbiology. 143:1997;1933-1940.
24. Gauntt C.D., Ohira A., Honda O., Kigasawa K., Fujimoto T., Masutani H., Yodoi J., Honda Y. Mitochondrial induction of adult T cell leukemia derived factor (ADF/hTx) after oxidative stresses in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 35:1994;2916-2923.
25. Hori K., Katayama M., Sato N., Ishii K., Waga S., Yodoi J. Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX). Brain Res. 652:1994;304-310.
26. Blum H., Rollinghoff M., Gessner A. Expression and co-cytokine function of murine thioredoxin/adult T cell leukaemia-derived factor (ADF). Cytokine. 8:1996;6-13.
27. Go T., Isowa N., Hirata T., Yodoi J., Hitomi S., Wada H. Thymic interdigitating cells express thioredoxin (TRX/ADF): an immunohistochemical study of 82 thymus and thymoma samples. Thymus. 24:1997;157-171.
28. Biguet C., Wakasugi N., Mishal Z., Holmgren A., Chouaib S., Tursz T., Wakasugi H. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J Biol Chem. 269:1994;28865-28870.
29. Buhl W.J. Annexins and phospholipase A2 inhibition. Eicosanoids. 5(Suppl):1992;26-28.
30. Ahluwalia A., Newbold P., Brain S.D., Flower R.J. Topical glucocorticoids inhibit neurogenic inflammation: involvement of lipocortin 1. Eur J Pharmacol. 283:1995;193-198.
31. Croxtall J.D., Choudhury Q., Newman S., Flower R.J. Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGE stimulation of cPLA2 phosphorylation. Biochem Pharmacol. 52:1996;351-356.
32. Dubois T., Oudinet J.P., Mira J.P., Russo Marie F. Annexins and protein kinases C. Biochim Biophys Acta. 1313:1996;290-294.
33. Ahn S.H., Sawada H., Ro J.Y., Nicolson G.L. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis. 15:1997;151-156.
34. Buckingham J.C., Flower R.J. Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis. Mol Med Today. 3:1997;296-302.
35. Johnstone S.A., Hubaishy I., Waisman D.M. Regulation of annexin I-dependent aggregation of phospholipid vesicles by protein kinase C. Biochem J. 294:1993;801-807.
36. Andree H.A., Willems G.M., Hauptmann R., Maurer Fogy I., Stuart M.C., Hermens W.T., Frederik P.M., Reutelingsperger C.P. Aggregation of phospholipid vesicles by a chimeric protein with the N-terminus of annexin I and the core of annexin V. Biochemistry. 32:1993;4634-4640.
37. Francia G., Mitchell S.D., Moss S.E., Hanby A.M., Marshall J.F., Hart I.R. Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res. 56:1996;3855-3858.
38. Schwartz Albiez R., Koretz K., Moller P., Wirl G. Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. Differentiation. 52:1993;229-237.
39. Masaki T., Tokuda M., Fujimura T., Ohnishi M., Tai Y., Miyamoto K., Itano T., Matsui H., Watanabe S., Sogawa K.et al. Involvement of annexin I and annexin II in hepatocyte proliferation: can annexins I and II be markers for proliferative hepatocytes? Hepatology. 20:1994;425-435.
40. Masaki T., Tokuda M., Ohnishi M., Watanabe S., Fujimura T., Miyamoto K., Itano T., Matsui H., Arima K., Shirai M., Maeba T., Sogawa K., Konishi R., Taniguchi K., Hatanaka Y., Hatase O., Nishioka M. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology. 24:1996;72-81.
41. Weinman J.S., Feinberg J.M., Rainteau D.P., Gaspera B.D., Weinman S.J. Annexins in rat enterocyte and hepatocyte: an immunogold electronmicroscope study. Cell Tissue Res. 278:1994;389-397.
42. McKanna J.A. Lipocortin 1 in apoptosis: mammary regression. Anat Rec. 242:1995;1-10.
43. 2-treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun. 220:1996;643-647.